Breaking the Preclinical-to-Clinical Bottleneck: Advancing Novel Theranostic Radiopharmaceuticals into First-in-Human Trials

Name: Breaking the Preclinical-to-Clinical Bottleneck: Advancing Novel Theranostic Radiopharmaceuticals into First-in-Human Trials
Start: 2026-12-02T12:00
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 2 December 2026 · 12:00

Breaking the Preclinical-to-Clinical Bottleneck: Advancing Novel Theranostic Radiopharmaceuticals into First-in-Human Trials was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 2 December 2026 in London, with 1 speaker on record.

Speakers

Friedmund Bachmann — Speaker Vice President CMC & Project Lead, OncoOne